X-152846395-A-G
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_015922.3(NSDHL):āc.71A>Gā(p.Lys24Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000563 in 1,206,950 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NSDHL | NM_015922.3 | c.71A>G | p.Lys24Arg | missense_variant | 2/8 | ENST00000370274.8 | NP_057006.1 | |
NSDHL | NM_001129765.2 | c.71A>G | p.Lys24Arg | missense_variant | 3/9 | NP_001123237.1 | ||
NSDHL | XM_017029564.2 | c.119A>G | p.Lys40Arg | missense_variant | 2/8 | XP_016885053.1 | ||
NSDHL | XM_011531178.3 | c.71A>G | p.Lys24Arg | missense_variant | 4/10 | XP_011529480.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NSDHL | ENST00000370274.8 | c.71A>G | p.Lys24Arg | missense_variant | 2/8 | 1 | NM_015922.3 | ENSP00000359297.3 | ||
NSDHL | ENST00000440023.5 | c.71A>G | p.Lys24Arg | missense_variant | 3/9 | 5 | ENSP00000391854.1 | |||
NSDHL | ENST00000432467.1 | c.71A>G | p.Lys24Arg | missense_variant | 3/8 | 3 | ENSP00000396266.1 |
Frequencies
GnomAD3 genomes AF: 0.0000355 AC: 4AN: 112712Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34850
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183429Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67873
GnomAD4 exome AF: 0.0000585 AC: 64AN: 1094238Hom.: 0 Cov.: 29 AF XY: 0.0000473 AC XY: 17AN XY: 359666
GnomAD4 genome AF: 0.0000355 AC: 4AN: 112712Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34850
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | NSDHL: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 28, 2022 | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 24 of the NSDHL protein (p.Lys24Arg). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with NSDHL-related conditions. This variant is present in population databases (rs201339444, gnomAD 0.004%), including at least one homozygous and/or hemizygous individual. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at